Investigators have developed STITCHR, a new gene editing tool that can insert therapeutic genes into specific locations without causing unwanted mutations. The system can be formulated completely as ...

CRISPR-Cas9 gene editing technology has emerged as one of the most transformative advancements in medicine and biotechnology.

Analysts at Precedence Research expect the gene-editing market to grow 15.7% annually and reach $40.1 billion by 2034, ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

You might have heard of them from mRNA vaccines. Now, researchers are using this same technology to deliver CRISPR—the powerful gene-editing tool—straight into tumor cells. CRISPR is like a ...

At meeting on human embryo editing, CRISPR pioneer says science is a long way from knowing if germline DNA can be safely ...

Colossal Biosciences—the company whose mission is “de-extinction”—has pulled off one of the wildest feats in modern science: ...

Since that discovery, a flurry of gene-editing focused biopharma companies have launched – including Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences and Mammoth Biosciences ...

CRISPR gene-editing technology offers curative potential for genetic diseases. The gene-editing market is projected to reach $30.8 billion by 2032. Top gene-editing pioneers include Intellia ...

CRISPR MarketThe CRISPR Market had an estimated market share worth USD 3.4 billion in 2023, and it is predicted to reach a global market valuation of USD 17.8 billion by 2034, growing at a CAGR of 16.

ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Jumpcode Genomics ('Jumpcode'), a life science tools company ...

Get Instant Summarized Text (Gist) An enhanced CRISPR tool, CRISPR-Cas12a, has been developed to enable simultaneous assessment of multiple genetic changes, improving disease modeling and gene editing ...